close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

91.14 +0.16 (+0.18%)
Official Closing Price Updated: 7:00 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
From Revvity
Via Business Wire
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
From Revvity
Via Business Wire
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
From Revvity
Via Business Wire
Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
From Revvity
Via Business Wire
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
The Latest Analyst Ratings For Revvity
 
Via Benzinga
Peeling Back The Layers: Exploring Revvity Through Analyst Insights
 
Via Benzinga
7 Analysts Have This to Say About Revvity
 
Via Benzinga
Why Revvity Stock Plunged Today
Revvity announced disappointing results and lowered its full-year outlook. Here's what investors need to know. 
Via The Motley Fool
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
Earnings Preview For Revvity
 
Via Benzinga
Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance
From Revvity
Via Business Wire
Revvity to Present at J.P. Morgan Healthcare Conference
From Revvity
Via Business Wire
NYSE: RVTY Investor Notice: Investigation over Possible Securities Laws Violations by Revvity, Inc.
San Diego, CA -- (SBWIRE) -- 12/11/2023 -- Revvity, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Revvity to Present at Annual Evercore ISI HealthCONx Conference
From Revvity
Via Business Wire
Earnings Outlook For Revvity
 
Via Benzinga
What 6 Analyst Ratings Have To Say About Revvity
 
Via Benzinga
The Latest Analyst Ratings for Revvity
 
Via Benzinga
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash. 
Via Benzinga
Why Biotechnology Company Revvity's Shares Diving Today
Revvity Inc (NYSE: RVTY) shares are trading lower by around 17% after the company reported worse-than-expected Q3 FY23 results and  
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Revvity Announces Financial Results for the Third Quarter of 2023
From Revvity
Via Business Wire
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Revvity Debuts Inaugural ESG Report
From Revvity
Via Business Wire
Revvity To Hold Earnings Call on Monday, October 30, 2023
From Revvity
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
 
Via Benzinga
Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure
From Revvity
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today